| scholarly article | Q13442814 |
| P50 | author | Roy Curtiss | Q7372720 |
| P2093 | author name string | Wei Sun | |
| Yuhua Li | |||
| Kenneth L Roland | |||
| Shifeng Wang | |||
| Huoying Shi | |||
| P2860 | cites work | pH-dependent secretion of SseB, a product of the SPI-2 type III secretion system of Salmonella typhimurium | Q50125208 |
| Th1 dominance in the immune response to live Salmonella typhimurium requires bacterial invasiveness but not persistence | Q50126498 | ||
| Environmental regulation of Salmonella pathogenicity island 2 gene expression | Q50126816 | ||
| Immunogenicity of viral B-cell epitopes inserted into two surface loops of the Escherichia coli K12 LamB protein and expressed in an attenuated aroA strain of Salmonella typhimurium | Q50127205 | ||
| Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium. | Q50131250 | ||
| A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens | Q50134864 | ||
| Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages. | Q50163402 | ||
| Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine | Q50174904 | ||
| A chromosomal integration system for stabilization of heterologous genes in Salmonella based vaccine strains | Q50197025 | ||
| Stable episomal expression system under control of a stress inducible promoter enhances the immunogenicity of Bacillus subtilis as a vector for antigen delivery. | Q54469903 | ||
| PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice | Q71619831 | ||
| IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin | Q74106308 | ||
| A Salmonella typhimurium virulence protein is similar to a Yersinia enterocolitica invasion protein and a bacteriophage lambda outer membrane protein | Q24681193 | ||
| H-NS mediates the silencing of laterally acquired genes in bacteria | Q28490022 | ||
| Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli | Q29615261 | ||
| Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes | Q30712206 | ||
| Examination of Salmonella gene expression in an infected mammalian host using the green fluorescent protein and two-colour flow cytometry | Q30828698 | ||
| Interleukin-17A mediates acquired immunity to pneumococcal colonization | Q33370537 | ||
| lac repressor is an antivirulence factor of Salmonella enterica: its role in the evolution of virulence in Salmonella | Q33460439 | ||
| Optimization of Salmonella enterica serovar typhi DeltaaroC DeltassaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters | Q33556968 | ||
| A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors | Q33557714 | ||
| A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. | Q33752525 | ||
| Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters. | Q33755979 | ||
| Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice | Q33877252 | ||
| SlyA regulates function of Salmonella pathogenicity island 2 (SPI-2) and expression of SPI-2-associated genes | Q33883333 | ||
| Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine | Q33963100 | ||
| Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium | Q34002047 | ||
| Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. | Q34002657 | ||
| In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae | Q34003489 | ||
| Construction and characterization of a Salmonella enterica serovar typhimurium clone expressing a salivary adhesin of Streptococcus mutans under control of the anaerobically inducible nirB promoter | Q34003662 | ||
| Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers | Q34003941 | ||
| Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses | Q34009711 | ||
| Aromatic-dependent salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them | Q34041923 | ||
| Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity | Q34119481 | ||
| Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine | Q34120949 | ||
| Negative regulation of Salmonella pathogenicity island 2 is required for contextual control of virulence during typhoid | Q34161056 | ||
| Intracellular bacteria as targets and carriers for vaccination | Q34280918 | ||
| Efficacy of intracellular activated promoters for generation of Salmonella-based vaccines | Q34290850 | ||
| Transfer of eukaryotic expression plasmids to mammalian host cells by bacterial carriers | Q34403839 | ||
| Transcriptome of Salmonella enterica serovar Typhi within macrophages revealed through the selective capture of transcribed sequences | Q34478638 | ||
| Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity | Q34515348 | ||
| Further characterization of the PhoP regulon: identification of new PhoP-activated virulence loci | Q34545309 | ||
| Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain | Q34716080 | ||
| Delineation of upstream signaling events in the salmonella pathogenicity island 2 transcriptional activation pathway. | Q35272629 | ||
| Runaway-replication plasmids as tools to produce large quantities of proteins from cloned genes in bacteria | Q35302873 | ||
| Acidification of phagosomes containing Salmonella typhimurium in murine macrophages. | Q35506318 | ||
| Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. | Q35533712 | ||
| A recombinant Bacillus anthracis strain producing the Clostridium perfringens Ib component induces protection against iota toxins | Q35548328 | ||
| Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. | Q35779035 | ||
| Bacterial infection as assessed by in vivo gene expression | Q35966527 | ||
| Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet? | Q36837160 | ||
| Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxins | Q36949983 | ||
| An unusual pagC::TnphoA mutation leads to an invasion- and virulence-defective phenotype in Salmonellae | Q36950718 | ||
| Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. | Q37062098 | ||
| Salmonella enterica serovar Typhi live vector vaccines finally come of age | Q37106127 | ||
| A global role for Fis in the transcriptional control of metabolism and type III secretion in Salmonella enterica serovar Typhimurium. | Q38338833 | ||
| A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge | Q38443037 | ||
| The response regulator SsrB activates expression of diverse Salmonella pathogenicity island 2 promoters and counters silencing by the nucleoid-associated protein H-NS. | Q39332980 | ||
| OmpR regulates the two-component system SsrA-ssrB in Salmonella pathogenicity island 2. | Q39498843 | ||
| Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. | Q39513282 | ||
| Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection | Q39519924 | ||
| Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen | Q39656225 | ||
| Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo | Q40171422 | ||
| Fis is required for proper regulation of ssaG expression in Salmonella enterica serovar Typhimurium | Q40267411 | ||
| Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines | Q40444726 | ||
| Rational design of Salmonella-based vaccination strategies | Q40488602 | ||
| Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C. | Q40613747 | ||
| phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. | Q40668237 | ||
| Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. | Q40674810 | ||
| Enhanced immune responses to viral epitopes by combining macrophage-inducible expression with multimeric display on a Salmonella vector | Q40815708 | ||
| Fluorescence-based isolation of bacterial genes expressed within host cells | Q41090281 | ||
| Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague | Q41450645 | ||
| Antibody responses to Yersinia pestis F1-antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters | Q41479815 | ||
| Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues | Q41632896 | ||
| Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans | Q41886615 | ||
| Formation of a novel surface structure encoded by Salmonella Pathogenicity Island 2. | Q42023974 | ||
| Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica | Q43533379 | ||
| The PhoP/PhoQ system controls the intramacrophage type three secretion system of Salmonella enterica | Q44016971 | ||
| Metabolic adaptation of Escherichia coli during temperature-induced recombinant protein production: 1. Readjustment of metabolic enzyme synthesis | Q44134222 | ||
| Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F H(C) fragment | Q44297896 | ||
| Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen | Q44761763 | ||
| The roles of SsrA-SsrB and OmpR-EnvZ in the regulation of genes encoding the Salmonella typhimurium SPI-2 type III secretion system | Q45020170 | ||
| Can a 'flawless' live vector vaccine strain be engineered? | Q45197812 | ||
| An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: export of Shiga-like toxin IIeB subunit by Salmonella typhimurium aroA. | Q47960715 | ||
| Expression of in vivo-inducible Salmonella enterica promoters during infection of Caenorhabditis elegans | Q50065619 | ||
| Investigation of ansB and sspA derived promoters for multi- and single-copy antigen expression in attenuated Salmonella enterica var. typhimurium | Q50089440 | ||
| Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ. | Q50091911 | ||
| The response regulator SsrB activates transcription and binds to a region overlapping OmpR binding sites at Salmonella pathogenicity island 2. | Q50095966 | ||
| Expression and secretion of Salmonella pathogenicity island-2 virulence genes in response to acidification exhibit differential requirements of a functional type III secretion apparatus and SsaL. | Q50096705 | ||
| Expression of heterologous antigens in Salmonella Typhimurium vaccine vectors using the in vivo-inducible, SPI-2 promoter, ssaG. | Q50097559 | ||
| Dual regulation by phospho-OmpR of ssrA/B gene expression in Salmonella pathogenicity island 2. | Q50103896 | ||
| Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA. | Q50117339 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | attenuated vaccine | Q1810913 |
| P304 | page(s) | 937-949 | |
| P577 | publication date | 2010-12-06 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines | |
| P478 | volume | 79 |
| Q91750540 | A Novel Cre Recombinase-Mediated In Vivo Minicircle DNA (CRIM) Vaccine Provides Partial Protection against Newcastle Disease Virus |
| Q37123734 | A colanic acid operon deletion mutation enhances induction of early antibody responses by live attenuated Salmonella vaccine strains |
| Q35213546 | A quorum sensing-based in vivo expression system and its application in multivalent bacterial vaccine |
| Q37425256 | Assessment of attenuated Salmonella vaccine strains in controlling experimental Salmonella Typhimurium infection in chickens |
| Q34421752 | Comparative immunological evaluation of recombinant Salmonella Typhimurium strains expressing model antigens as live oral vaccines |
| Q34316015 | Development of Streptococcus pneumoniae Vaccines Using Live Vectors |
| Q34627454 | Development of a Fur-dependent and tightly regulated expression system in Escherichia coli for toxic protein synthesis |
| Q94587492 | Differentially regulated promoters for antigen expression in Salmonella vaccine strains |
| Q47127930 | Evaluation of Recombinant Attenuated Salmonella Vaccine Strains for Broad Protection against Extraintestinal Pathogenic Escherichia coli |
| Q36911282 | Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar Typhi vaccine vectors in neonatal and infant mice |
| Q35829353 | In Vivo Programmed Gene Expression Based on Artificial Quorum Networks |
| Q34298699 | LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague |
| Q28084076 | Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery |
| Q36970553 | Low-pH rescue of acid-sensitive Salmonella enterica Serovar Typhi Strains by a Rhamnose-regulated arginine decarboxylase system |
| Q36653379 | New technologies in developing recombinant attenuated Salmonella vaccine vectors |
| Q41868899 | Novel methods for expression of foreign antigens in live vector vaccines |
| Q36372952 | Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague |
| Q91689946 | Regulated Delayed Shigella flexneri 2a O-antigen Synthesis in Live Recombinant Salmonella enterica Serovar Typhimurium Induces Comparable Levels of Protective Immune Responses with Constitutive Antigen Synthesis System |
| Q49644946 | Salmonella Vaccines: Conduits for Protective Antigens |
| Q27011946 | Salmonella as a vaccine delivery vehicle |
| Q50016846 | Utilizing Salmonella for antigen delivery: the aims and benefits of bacterial delivered vaccination |
Search more.